ZCL278: Selective Cdc42 Inhibitor for Cell Motility & Fib...
2025-10-21
ZCL278, a potent and selective small molecule Cdc42 inhibitor, is redefining experimental strategies in cancer cell migration, neuronal development, and fibrotic disease modeling. This guide details optimized workflows, troubleshooting, and advanced applications, empowering researchers to harness Cdc42 GTPase inhibition for translational breakthroughs. Discover how ZCL278 stands apart in Rho family GTPase regulation and disease pathway interrogation.